Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05837949 · ClinicalTrials.gov registry record · NA

Multiple Sclerosis Falls Insight Track

A NA study of Multiple Sclerosis, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05837949 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05837949, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop an application: MS Falls Insight Track (MS FIT) which allows patients to log their falls and near falls, view their MS relevant data and responses to the clinic intake survey as well as communicate with their care team about falls and receive educational material on falls prevention.

Conditions Studied

Interventions

  • BEHAVIORAL MS FIT: Falls Insight Track

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-04-12
Est. Completion 2026-01-01
Phase NA

What the Registry Record Tells You About NCT05837949

The ClinicalTrials.gov registry entry for NCT05837949 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (83% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which MS FIT: Falls Insight Track is the first listed.

NCT05837949 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05837949 about?

NCT05837949 is a clinical study titled "Multiple Sclerosis Falls Insight Track". The purpose of this study is to develop an application: MS Falls Insight Track (MS FIT) which allows patients to log their falls and near falls, view their MS relevant data and responses to the clinic intake survey as well as communicate with their care team about falls and receive educational mater...

What is the current status of trial NCT05837949?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-04-12. Estimated completion is 2026-01-01.

What conditions does trial NCT05837949 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05837949?

The interventions under investigation include: MS FIT: Falls Insight Track (BEHAVIORAL).

Who is sponsoring clinical trial NCT05837949?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05837949 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.